365 related articles for article (PubMed ID: 19169123)
1. Adherence to quality indicators and survival in patients with breast cancer.
Cheng SH; Wang CJ; Lin JL; Horng CF; Lu MC; Asch SM; Hilborne LH; Liu MC; Chen CM; Huang AT
Med Care; 2009 Feb; 47(2):217-25. PubMed ID: 19169123
[TBL] [Abstract][Full Text] [Related]
2. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
[TBL] [Abstract][Full Text] [Related]
3. Using a bubble chart to enhance adherence to quality-of-care guidelines for colorectal cancer patients.
Chien TW; Lin YF; Chang CH; Tsai MT; Uen YH
Eur J Cancer Care (Engl); 2012 Nov; 21(6):712-21. PubMed ID: 22335545
[TBL] [Abstract][Full Text] [Related]
4. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
[TBL] [Abstract][Full Text] [Related]
5. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?
Malin JL; Schneider EC; Epstein AM; Adams J; Emanuel EJ; Kahn KL
J Clin Oncol; 2006 Feb; 24(4):626-34. PubMed ID: 16401682
[TBL] [Abstract][Full Text] [Related]
6. Effect of preoperative short course famotidine on TILs and survival in breast cancer.
Parshad R; Hazrah P; Kumar S; Gupta SD; Ray R; Bal S
Indian J Cancer; 2005; 42(4):185-90. PubMed ID: 16391436
[TBL] [Abstract][Full Text] [Related]
7. [Benchmarking: how to measure outcome quality at the comprehensive oncology centre in Stuttgart].
Meisner C; Brinkmann F; Henke D; Junack C; Faisst S; Heidemann E
Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):365-70. PubMed ID: 21767795
[TBL] [Abstract][Full Text] [Related]
8. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
9. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients.
Trinh XB; Tjalma WA; Makar AP; Buytaert G; Weyler J; van Dam PA
Fertil Steril; 2008 Jul; 90(1):17-22. PubMed ID: 17706209
[TBL] [Abstract][Full Text] [Related]
10. Treatment choice and quality of care for men with localized prostate cancer.
Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
[TBL] [Abstract][Full Text] [Related]
11. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
Giraldes Mdo R
Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
[TBL] [Abstract][Full Text] [Related]
12. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
13. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.
Dew JE; Wren BG; Eden JA
Climacteric; 2003 Mar; 6(1):45-52. PubMed ID: 12725664
[TBL] [Abstract][Full Text] [Related]
14. Changes in health-related quality of life may predict recurrent breast cancer.
Kenne Sarenmalm E; Odén A; Ohlén J; Gaston-Johansson F; Holmberg SB
Eur J Oncol Nurs; 2009 Dec; 13(5):323-9. PubMed ID: 19596212
[TBL] [Abstract][Full Text] [Related]
15. Developing and measuring a set of process and outcome indicators for breast cancer.
Stordeur S; Vrijens F; Devriese S; Beirens K; Van Eycken E; Vlayen J
Breast; 2012 Jun; 21(3):253-60. PubMed ID: 22056787
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer.
Bewick MA; Conlon MS; Lafrenie RM
Breast Cancer Res Treat; 2008 Sep; 111(1):93-101. PubMed ID: 17922231
[TBL] [Abstract][Full Text] [Related]
17. Multifocal breast cancer in women < or =35 years old.
Litton JK; Eralp Y; Gonzalez-Angulo AM; Broglio K; Uyei A; Hortobagyi GN; Arun B
Cancer; 2007 Oct; 110(7):1445-50. PubMed ID: 17676585
[TBL] [Abstract][Full Text] [Related]
18. The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence.
Chen SL; Martinez SR
Am J Surg; 2008 Oct; 196(4):495-9. PubMed ID: 18809050
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
20. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
